Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.09 | $0.10 | $0.09 |
| Q2 2026 | 1 | $0.11 | $0.11 | $0.11 |
| Q3 2026 | 2 | $0.21 | $0.21 | $0.21 |
| Q4 2026 | 1 | $0.20 | $0.21 | $0.21 |
| Q1 2027 | 1 | $0.14 | $0.14 | $0.14 |
| Q2 2027 | 1 | $0.21 | $0.21 | $0.21 |
| Q3 2027 | 1 | $0.24 | $0.24 | $0.24 |
| Q4 2027 | 1 | $0.23 | $0.23 | $0.23 |
Core Laboratories Inc last posted its earnings results on Wednesday, April 29th, 2026. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0. The company had revenue of 121.80 M for the quarter and had revenue of 526.52 M for the year. Core Laboratories Inc has generated $1 earnings per share over the last year ($0.68 diluted earnings per share) and currently has a price-to-earnings ratio of 20.84. Core Laboratories Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/29/2026 | Q1 2026 | $0.06 | -$0.02 | -0.08 | $122.99 M | $121.80 M |
| 03/20/2026 | Q4 2025 | N/A | $0.15 | N/A | $132.13 M | $138.26 M |
| 10/23/2025 | Q3 2025 | N/A | $0.30 | N/A | $131.22 M | $134.52 M |
| 07/24/2025 | Q2 2025 | N/A | $0.22 | N/A | $129.13 M | $130.16 M |
| 04/25/2025 | Q1 2025 | N/A | -$0.00 | N/A | $124.38 M | $123.59 M |
| 02/12/2025 | Q4 2024 | N/A | $0.16 | N/A | $132.18 M | $129.24 M |
| 10/24/2024 | Q3 2024 | N/A | $0.25 | N/A | $134.16 M | $134.40 M |
| 07/25/2024 | Q2 2024 | N/A | $0.19 | N/A | $132.85 M | $130.58 M |
| 04/25/2024 | Q1 2024 | N/A | $0.07 | N/A | $124.13 M | $129.64 M |
| 02/14/2024 | Q4 2023 | N/A | $0.05 | N/A | N/A | $128.21 M |
| 11/02/2023 | Q3 2023 | N/A | $0.20 | N/A | N/A | $125.34 M |
| 07/27/2023 | Q2 2023 | N/A | $0.49 | N/A | N/A | $127.88 M |
| 04/27/2023 | Q1 2023 | N/A | $0.05 | N/A | N/A | $128.36 M |
| 02/09/2023 | Q4 2022 | N/A | $0.15 | N/A | N/A | $127.57 M |
| 10/27/2022 | Q3 2022 | N/A | $0.16 | N/A | N/A | $125.97 M |
| 07/28/2022 | Q2 2022 | N/A | $0.15 | N/A | N/A | $120.90 M |
| 04/28/2022 | Q1 2022 | N/A | -$0.04 | N/A | N/A | $115.30 M |
| 02/10/2022 | Q4 2021 | N/A | $0.06 | N/A | N/A | $125.14 M |
| 10/28/2021 | Q3 2021 | N/A | $0.02 | N/A | N/A | $117.99 M |
| 07/29/2021 | Q2 2021 | N/A | $0.17 | N/A | N/A | $118.75 M |
The conference call for Core Laboratories Inc's latest earnings report can be listened to online.
The conference call transcript for Core Laboratories Inc's latest earnings report can be read online.
Core Laboratories Inc (:CLB) has a recorded annual revenue of $526.52 M.
Core Laboratories Inc (:CLB) has a recorded net income of $29.67 M.Core Laboratories Inc has generated $0.68 earnings per share over the last four quarters.
Core Laboratories Inc (:CLB) has a price-to-earnings ratio of 20.84 and price/earnings-to-growth ratio is 2.5.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED